If a drug sounds too good to be true, it probably is. The story of U.S. Food and Drug Administration drug approvals is more complex than how the Wall Street Journal's editorial page makes it seem. Listen as FDA Commissioner Dr. Makary explains how pharmaceutical companies sell their sob stories through their lobbyists and advertising partners. | U.S. Department of Health and Human Services